Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
R. A Van Hogezand & N. A. T. Hamdy. (2006) Skeletal morbidity in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 41:sup243, pages 59-64.
Read now
Read now
J. Jahnsen, J. A. Falch, P. Mowinckel & E. Aadland. (2004) Bone mineral density in patients with inflammatory bowel disease: A population‐based prospective two‐year follow‐up study. Scandinavian Journal of Gastroenterology 39:2, pages 145-153.
Read now
Read now
Articles from other publishers (40)
A. A. van Bodegraven & N. Bravenboer. (2019) Perspective on skeletal health in inflammatory bowel disease. Osteoporosis International 31:4, pages 637-646.
Crossref
Crossref
Herman Bami, Arthur N. Lau & Jonathan D. Adachi. 2019. Evidence‐based Gastroenterology and Hepatology 4e. Evidence‐based Gastroenterology and Hepatology 4e
240
257
.
Amna NaserAhmad QasemSaleh A. Naser. (2018) Mycobacterial infection influences bone biomarker levels in patients with Crohn’s disease. Canadian Journal of Physiology and Pharmacology 96:7, pages 662-667.
Crossref
Crossref
Solvey Schüle, Jean-Benoît Rossel, Diana Frey, Luc Biedermann, Michael Scharl, Jonas Zeitz, Natália Freitas-Queiroz, Thomas Kuntzen, Thomas Greuter, Stephan R. Vavricka, Gerhard Rogler & Benjamin Misselwitz. (2017) Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study. Medicine 96:22, pages e6788.
Crossref
Crossref
Solvey Schüle, Jean‐Benoît Rossel, Diana Frey, Luc Biedermann, Michael Scharl, Jonas Zeitz, Natália Freitas‐Queiroz, Valérie Pittet, Stephan R Vavricka, Gerhard Rogler & Benjamin Misselwitz. (2016) Prediction of low bone mineral density in patients with inflammatory bowel diseases. United European Gastroenterology Journal 4:5, pages 669-676.
Crossref
Crossref
Neveen A.T. Hamdy. 2013. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
489
494
.
Sjoerd F. Bakker, Vincent K. Dik, Birgit I. Witte, Paul Lips, Jan C. Roos & Adriaan A. Van Bodegraven. (2013) Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation. Journal of Crohn's and Colitis 7:5, pages 377-384.
Crossref
Crossref
Neville Azzopardi & Pierre Ellul. (2013) Risk Factors for Osteoporosis in Crohnʼs Disease. Inflammatory Bowel Diseases 19:6, pages 1173-1178.
Crossref
Crossref
Marília Cravo, Catarina Sousa Guerreiro, Paula Moura dos Santos, Miguel Brito, Paula Ferreira, Catarina Fidalgo, Lourdes Tavares & António Dias Pereira. (2010) Risk factors for metabolic bone disease in Crohnʼs disease patients. Inflammatory Bowel Diseases 16:12, pages 2117-2124.
Crossref
Crossref
Ann Cranney, Alaa Rostom, Catherine Dubé, Rachid Mohamed, Peter Tugwell, George Wells & John WD McDonald. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology
280
300
.
Pál Miheller, Péter L. Lakatos & Miklós Tóth. (2010) Bone Homeostasis in Intestinal Disorders. Clinical Reviews in Bone and Mineral Metabolism 8:3, pages 140-148.
Crossref
Crossref
C. Kok & P.N. Sambrook. (2009) Secondary osteoporosis in patients with an osteoporotic fracture. Best Practice & Research Clinical Rheumatology 23:6, pages 769-779.
Crossref
Crossref
Neveen A. T. Hamdy. 2008. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
276
279
.
Max Reinshagen. (2008) Osteoporosis in inflammatory bowel disease. Journal of Crohn's and Colitis 2:3, pages 202-207.
Crossref
Crossref
A. Dignass. (2007) Chronisch-entzündlichen DarmerkrankungenChronic inflammatory bowel diseases. Der Gastroenterologe 2:6, pages 440-446.
Crossref
Crossref
Gary R. Lichtenstein, Bruce E. Sands & Michael Pazianas. (2006) Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflammatory Bowel Diseases 12:8, pages 797-813.
Crossref
Crossref
R. A. van Hogezand, D. Bänffer, A. H. Zwinderman, E. V. McCloskey, G. Griffioen & N. A. T. Hamdy. (2006) Ileum resection is the most predictive factor for osteoporosis in patients with Crohn’s disease. Osteoporosis International 17:4, pages 535-542.
Crossref
Crossref
Sarah A Bartram. (2006) Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn’s disease. World Journal of Gastroenterology 12:35, pages 5680.
Crossref
Crossref
Subrata Ghosh. 2006. Challenges in Inflammatory Bowel Disease. Challenges in Inflammatory Bowel Disease
340
359
.
Naomi Lee, Graham Radford-SmithDr.Dr. & Dennis R Taaffe. (2005) Bone Loss in Crohnʼs Disease: Exercise As a Potential Countermeasure. Inflammatory Bowel Diseases 11:12, pages 1108-1118.
Crossref
Crossref
Nathalie Demerjian-Somogyi, Elisabeth Palazzo & Martine Cohen-Solal. (2005) Ostéoporose des maladies inflammatoires chroniques de l'intestin. Revue du Rhumatisme 72:9, pages 764-766.
Crossref
Crossref
Nathalie Demerjian-Somogyi, Elisabeth Palazzo & Martine Cohen-Solal. (2005) Osteoporosis in patients with inflammatory bowel disease. Joint Bone Spine 72:5, pages 354-356.
Crossref
Crossref
Ann Cranney, Catherine Dube, Alaa Rostom, Peter Tugwell & George Wells. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology
231
246
.
J. H. Tobias, M. R. Sasi, R. Greenwood & C. S. J. Probert. (2004) Rapid hip bone loss in active Crohn's disease patients receiving short-term corticosteroid therapy. Alimentary Pharmacology & Therapeutics 20:9, pages 951-957.
Crossref
Crossref
Charlene Compher & David Metz. 2004. Intestinal Failure and Rehabilitation. Intestinal Failure and Rehabilitation
115
127
.
C. N. Bernstein & W. D. Leslie. (2004) Osteoporosis and inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 19:9, pages 941-952.
Crossref
Crossref
Marc Lemann, Joëlle Bonnet, Matthieu Allez, Jean-Marc Gornet & Xavier Mariette. (2004) Lésions ostéo-articulaires au cours des maladies inflammatoires chroniques de l’intestin. Gastroentérologie Clinique et Biologique 28:5, pages 75-82.
Crossref
Crossref
S. A. Bartram, R. T. Peaston, D. J. Rawlings, R. M. Francis & N. P. Thompson. (2003) A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease. Alimentary Pharmacology & Therapeutics 18:11-12, pages 1121-1127.
Crossref
Crossref
Christian von Tirpitz, Sonja Epp, Jochen Klaus, Richard Mason, Gerhard Hawa, Natascha Brinskelle-Schmal, Lorenz C Hofbauer, Guido Adler, Wolfgang Kratzer & Max Reinshagen. (2003) Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease. European Journal of Gastroenterology & Hepatology 15:11, pages 1165-1170.
Crossref
Crossref
Edward V. LoftusJrJr, Sara J. Achenbach, William J. Sandborn, William J. Tremaine, Ann L. Oberg & L.Joseph MeltonIIIIII. (2003) Risk of fracture in ulcerative colitis: a population-based study from Olmsted county, Minnesota. Clinical Gastroenterology and Hepatology 1:6, pages 465-473.
Crossref
Crossref
Charles N. Bernstein, William D. Leslie & Meryl S. Leboff. (2003) AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 124:3, pages 795-841.
Crossref
Crossref
Max Reinshagen & Christian von Tirpitz. (2003) Osteoporosis and Other Extraintestinal Symptoms and Complications of Inflammatory Bowel Diseases. Digestive Diseases 21:2, pages 138-145.
Crossref
Crossref
D.J. Jong, F.H.M. Corstens, L. Mannaerts, L.G.M. Rossum & A.H.J. Naber. (2002) Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?. The American Journal of Gastroenterology 97:8, pages 2011-2015.
Crossref
Crossref
R. W. Stockbrügger, E. J. Schoon, S. Bollani, P. R. Mills, E. Israeli, L. Landgraf, D. Felsenberg, S. Ljunghall, G. Nygard, T. Persson, H. Graffner, G. Bianchi Porro & A. Ferguson. (2002) Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Alimentary Pharmacology & Therapeutics 16:8, pages 1519-1527.
Crossref
Crossref
Nicole Bregenzer, Peter Erban, Helga Albrich, Gerd Schmitz, Stefan Feuerbach, Jürgen Schölmerich & Tilo Andus. (2002) Screening for osteoporosis in patients with inflammatory bowel disease by using urinary N-telopeptides. European Journal of Gastroenterology & Hepatology 14:6, pages 599-605.
Crossref
Crossref
Maria Cino & Gordon R. Greenberg. (2002) Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy. The American Journal of Gastroenterology 97:4, pages 915-921.
Crossref
Crossref
C. Schulte. 2001. Chronisch entzündliche Darmerkrankungen. Chronisch entzündliche Darmerkrankungen
20
27
.
Charles N. Bernstein. (2000) Neoplastic and other complications of inflammatory bowel disease. Current Gastroenterology Reports 2:6, pages 451-459.
Crossref
Crossref
Claudia M.S. Schulte, Axel U. Dignass, Harald Goebell, Hans–Dietrich Röher & Klaus–Martin Schulte. (2000) Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterology 119:4, pages 909-920.
Crossref
Crossref
Matthieu Allez & Robert Modigliani. (2000) Clinical features of inflammatory bowel disease. Current Opinion in Gastroenterology 16:4, pages 329-336.
Crossref
Crossref